Death Receptors and Cognate Ligands in Cancer /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Colección: | Results and Problems in Cell Differentiation,
49 |
| Materias: |
Tabla de Contenidos:
- The Role of TNF in Cancer
- Many Checkpoints on the Road to Cell Death:Regulation of Fas–FasL Interactions and Fas Signaling in Peripheral Immune Responses
- FasL Expression and Reverse Signalling
- Impact of TNF-R1 and CD95 Internalization on Apoptotic and Antiapoptotic Signaling
- Ubiquitination and TNFR1 Signaling
- From Biochemical Principles of Apoptosis Induction by TRAIL to Application in Tumour Therapy
- Therapeutic Targeting of TWEAK/Fn14 in Cancer: Exploiting the Intrinsic Tumor Cell Killing Capacity of the Pathway
- APRIL in B-cell Malignancies and Autoimmunity
- Autophagy in Cancer and Chemotherapy
- Glucocorticoid-Mediated Apoptosis Resistance of Solid Tumors
- Targeting Death-Receptors in Radiation Therapy
- Death Ligands Designed to Kill: Development and Application of Targeted Cancer Therapeutics Based on Proapoptotic TNF Family Ligands.